Identification of proteins regulated by chlorogenic acid in an ischemic animal model: a proteomic approach

Abstract Background Cerebral ischemia is a serious neurological disorder that can lead to high morbidity and mortality. Chlorogenic acid is a polyphenol compound with antioxidant that can regulate proteins in cerebral ischemia. Middle cerebral artery occlusion (MCAO) surgery was performed to induce...

Full description

Bibliographic Details
Main Authors: Murad-Ali Shah, Ju-Bin Kang, Phil-Ok Koh
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Laboratory Animal Research
Subjects:
Online Access:https://doi.org/10.1186/s42826-023-00164-5
_version_ 1797806889690464256
author Murad-Ali Shah
Ju-Bin Kang
Phil-Ok Koh
author_facet Murad-Ali Shah
Ju-Bin Kang
Phil-Ok Koh
author_sort Murad-Ali Shah
collection DOAJ
description Abstract Background Cerebral ischemia is a serious neurological disorder that can lead to high morbidity and mortality. Chlorogenic acid is a polyphenol compound with antioxidant that can regulate proteins in cerebral ischemia. Middle cerebral artery occlusion (MCAO) surgery was performed to induce ischemic brain injury and was maintained for 24 h. Chlorogenic acid (30 mg/kg) or vehicle was administrated into the peritoneal cavity 2 h after MCAO surgery. The cerebral cortical tissues were collected for further study and a proteomic approach was performed to identify the proteins changed by chlorogenic acid in the MCAO animals. Results We found that chlorogenic acid alleviated in changes in adenosylhomocysteinase, glycerol-3-phosphate dehydrogenase, eukaryotic translation initiation factor 4A-II, apolipoprotein A-I, and mu-crystallin. These proteins were reduced in MCAO animals with vehicle, and these reductions were attenuated by chlorogenic acid treatment. The mitigation of this reduction by chlorogenic acid was confirmed by the reverse transcription PCR technique. These proteins are associated with energy metabolism, protein synthesis, inflammation, and physiological metabolism. They are involved in the neuroprotective effect of chlorogenic acid. These results showed that chlorogenic acid alleviates the neurological disorders caused by MCAO and regulates the expression of proteins involved in neuroprotection. Conclusions Therefore, our findings provide evidence that chlorogenic acid plays a neuroprotective role in stroke animal models by controlling specific proteins.
first_indexed 2024-03-13T06:14:14Z
format Article
id doaj.art-1634a48258ba4934afc0b11225e2c188
institution Directory Open Access Journal
issn 2233-7660
language English
last_indexed 2024-03-13T06:14:14Z
publishDate 2023-06-01
publisher BMC
record_format Article
series Laboratory Animal Research
spelling doaj.art-1634a48258ba4934afc0b11225e2c1882023-06-11T11:04:43ZengBMCLaboratory Animal Research2233-76602023-06-0139111210.1186/s42826-023-00164-5Identification of proteins regulated by chlorogenic acid in an ischemic animal model: a proteomic approachMurad-Ali Shah0Ju-Bin Kang1Phil-Ok Koh2Department of Anatomy, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National UniversityDepartment of Anatomy, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National UniversityDepartment of Anatomy, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National UniversityAbstract Background Cerebral ischemia is a serious neurological disorder that can lead to high morbidity and mortality. Chlorogenic acid is a polyphenol compound with antioxidant that can regulate proteins in cerebral ischemia. Middle cerebral artery occlusion (MCAO) surgery was performed to induce ischemic brain injury and was maintained for 24 h. Chlorogenic acid (30 mg/kg) or vehicle was administrated into the peritoneal cavity 2 h after MCAO surgery. The cerebral cortical tissues were collected for further study and a proteomic approach was performed to identify the proteins changed by chlorogenic acid in the MCAO animals. Results We found that chlorogenic acid alleviated in changes in adenosylhomocysteinase, glycerol-3-phosphate dehydrogenase, eukaryotic translation initiation factor 4A-II, apolipoprotein A-I, and mu-crystallin. These proteins were reduced in MCAO animals with vehicle, and these reductions were attenuated by chlorogenic acid treatment. The mitigation of this reduction by chlorogenic acid was confirmed by the reverse transcription PCR technique. These proteins are associated with energy metabolism, protein synthesis, inflammation, and physiological metabolism. They are involved in the neuroprotective effect of chlorogenic acid. These results showed that chlorogenic acid alleviates the neurological disorders caused by MCAO and regulates the expression of proteins involved in neuroprotection. Conclusions Therefore, our findings provide evidence that chlorogenic acid plays a neuroprotective role in stroke animal models by controlling specific proteins.https://doi.org/10.1186/s42826-023-00164-5Chlorogenic acidMiddle cerebral artery occlusionNeuroprotectionStroke
spellingShingle Murad-Ali Shah
Ju-Bin Kang
Phil-Ok Koh
Identification of proteins regulated by chlorogenic acid in an ischemic animal model: a proteomic approach
Laboratory Animal Research
Chlorogenic acid
Middle cerebral artery occlusion
Neuroprotection
Stroke
title Identification of proteins regulated by chlorogenic acid in an ischemic animal model: a proteomic approach
title_full Identification of proteins regulated by chlorogenic acid in an ischemic animal model: a proteomic approach
title_fullStr Identification of proteins regulated by chlorogenic acid in an ischemic animal model: a proteomic approach
title_full_unstemmed Identification of proteins regulated by chlorogenic acid in an ischemic animal model: a proteomic approach
title_short Identification of proteins regulated by chlorogenic acid in an ischemic animal model: a proteomic approach
title_sort identification of proteins regulated by chlorogenic acid in an ischemic animal model a proteomic approach
topic Chlorogenic acid
Middle cerebral artery occlusion
Neuroprotection
Stroke
url https://doi.org/10.1186/s42826-023-00164-5
work_keys_str_mv AT muradalishah identificationofproteinsregulatedbychlorogenicacidinanischemicanimalmodelaproteomicapproach
AT jubinkang identificationofproteinsregulatedbychlorogenicacidinanischemicanimalmodelaproteomicapproach
AT philokkoh identificationofproteinsregulatedbychlorogenicacidinanischemicanimalmodelaproteomicapproach